| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99233 |
Prolong inpt eval add15 m |
8,278 |
2,617 |
$300K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
17,206 |
5,016 |
$294K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,118 |
620 |
$247K |
| 99223 |
Prolong inpt eval add15 m |
2,739 |
2,494 |
$147K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
6,195 |
3,414 |
$112K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,373 |
1,089 |
$60K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
2,251 |
1,545 |
$48K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,292 |
1,166 |
$48K |
| 99222 |
Initial hospital care, per day, moderate complexity |
508 |
472 |
$29K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
325 |
282 |
$22K |
| 99306 |
Prolong nursin fac eval 15m |
394 |
368 |
$17K |
| 99254 |
|
265 |
257 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
386 |
354 |
$16K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
470 |
187 |
$12K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
348 |
314 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
49 |
18 |
$3K |
| 99253 |
|
65 |
64 |
$3K |
| 99305 |
|
33 |
26 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
42 |
38 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
41 |
18 |
$803.90 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
19 |
19 |
$626.70 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
31 |
15 |
$519.80 |
| 99406 |
|
52 |
50 |
$247.50 |